13F filer · CIK 1444043
Camber Capital Management LP
BOSTON, MA · filing since Q2 2013 · last filing Aug 14, 2025
Reported value
$1.1B
$-1.7B vs prior
Positions
25
New / sold out
4 / 11
Added / reduced
1 / 17
Turnover
6.9%
buys $134.6M · sells $1.9B
Top-10 weight
79.2%
Biggest buys vs Q1 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ICON PLC | +300,000 | – | +$43.6M |
| New | MERCK & CO INC | +500,000 | – | +$39.6M |
| New | UNITEDHEALTH GROUP INC | +100,000 | – | +$31.2M |
| New | APELLIS PHARMACEUTICALS INC | +850,000 | – | +$14.7M |
| Added | BIOMARIN PHARMACEUTICAL INC | +100,000 | +20.0% | +$5.5M |
Biggest sells vs Q1 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | SPYSPDR S&P 500 ETF TRPUT | -1,000,000 | -66.7% | $-617.9M |
| Sold out | PFIZER INCCALL | -6,800,000 | -100.0% | $-172.3M |
| Sold out | SPDR SER TRPUT | -2,000,000 | -100.0% | $-162.2M |
| Reduced | ZIMMER BIOMET HOLDINGS INC | -1,250,000 | -55.6% | $-114.0M |
| Reduced | HUMANA INC | -425,000 | -58.6% | $-103.9M |
| Reduced | BAXTER INTL INC | -2,900,000 | -50.4% | $-87.8M |
| Reduced | CVSCVS HEALTH CORP | -1,200,000 | -53.3% | $-82.8M |
| Sold out | PTC THERAPEUTICS INC | -1,500,000 | -100.0% | $-76.4M |
| Sold out | THE CIGNA GROUP | -200,000 | -100.0% | $-65.8M |
| Sold out | QIAGEN NV | -1,400,000 | -100.0% | $-56.2M |
18 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2025
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SPYSPDR S&P 500 ETF TRPUT | 500,000 | $308.9M | 29.00% |
| 2 | ZIMMER BIOMET HOLDINGS INCCOM | 1,000,000 | $91.2M | 8.56% |
| 3 | BAXTER INTL INCCOM | 2,850,000 | $86.3M | 8.10% |
| 4 | HUMANA INCCOM | 300,000 | $73.3M | 6.89% |
| 5 | CVSCVS HEALTH CORP | 1,050,000 | $72.4M | 6.80% |
| 6 | GLOBUS MED INCCL A | 800,000 | $47.2M | 4.43% |
| 7 | ICON PLCSHS | 300,000 | $43.6M | 4.10% |
| 8 | ASCENDIS PHARMA A/SSPONSORED ADR | 250,000 | $43.1M | 4.05% |
| 9 | MERCK & CO INCCOM | 500,000 | $39.6M | 3.72% |
| 10 | GSK PLCCALLSPONSORED ADR | 1,000,000 | $38.4M | 3.60% |
15 more rows. Subscribe for $29/month to see every row, download the data and use the API.